Archives

Pegrizeprument Granted Orphan Drug Designation for Prevention of Organ Rejection in Heart Transplant Patients

B CARY, N.C., April 22, 2026 /PRNewswire/ — Veloxis Pharmaceuticals, Inc. (Veloxis), a global specialty pharmaceutical company part of Asahi Kasei Corporation, announced today that pegrizeprument… Login to continue reading Login…

Read MorePegrizeprument Granted Orphan Drug Designation for Prevention of Organ Rejection in Heart Transplant Patients

Americans Are Redefining the Meaning of a Move: New PODS Study Finds Affordability and Connection Now Outweigh Career Opportunities

B Research Reveals Moving Has Become a “Fresh Start” Ritual Driven by Cost of Living, Community, and Emotional Well-Being CLEARWATER, Fla., April 22, 2026 /PRNewswire/… Login to continue reading Login…

Read MoreAmericans Are Redefining the Meaning of a Move: New PODS Study Finds Affordability and Connection Now Outweigh Career Opportunities